| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_704997ae3d7efaa9e0b08c26edd60f35 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d01996582ec3b646c70476ec044168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf940c2df298207a0175452f56b8905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15c4657d38b5058cdaff93e2397eb26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf65aa27a8f94cbe8049038cab54fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e475d5862492232d5f55218fe4b5f86 |
| publicationDate |
2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2975137-A1 |
| titleOfInvention |
Use of immune diversity as a predictive marker for identifying B-cell-lymphomas-patients having an increased risk of febrile or infectious event |
| abstract |
The present invention pertains to the field of cancer therapy and provides a predictive marker for determining if a patient suffering from a B-cell neoplasm can benefit from an anti-CD20-based chemotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022032257-A1 |
| priorityDate |
2014-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |